The Column Group

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies

Number of Investments

Number of Lead Investments

18

5

The Column Group has made 18 investments. Their most recent investment was on Nov 29, 2022, when Cajal Neuroscience raised $96M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Nov 29, 2022 Cajal Neuroscience	Series A	$96M	Biotechnology	Yes
Jan 6, 2022 Eikon Therapeutics	Series B	$518M	Biotechnology	—
May 5, 2021 Eikon Therapeutics	Series A	$148M	Biotechnology	Yes
Mar 1, 2021 Tenaya Therapeutics	Series C	$106M	Biopharma	—
Oct 6, 2020 A2 Biotherapeutics	Series B	$71.50M	Biotechnology	—